Terms: = Uterine cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Diagnosis
84 results:
1. Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
Heydarnia E; Dorostgou Z; Hedayati N; Mousavi V; Yahyazadeh S; Alimohammadi M; Gheibi M; Heidari P; Igder S; Mafi A; Vakili O
Cell Commun Signal; 2024 Feb; 22(1):107. PubMed ID: 38341592
[TBL] [Abstract] [Full Text] [Related]
2. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the akt/mTOR signaling pathway.
Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
[TBL] [Abstract] [Full Text] [Related]
3. Underestimated Cervical cancer among Women over 65 Years Old: Is It Time to Revise the Screening Target Age Group?
Zago RA; Camilo-Júnior DJ; D'Ávilla SCGP; Xavier-Júnior JCC
Rev Bras Ginecol Obstet; 2023 Dec; 45(12):e790-e795. PubMed ID: 38141600
[TBL] [Abstract] [Full Text] [Related]
4. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
Peng Q; Wang L; Zuo L; Gao S; Jiang X; Han Y; Lin J; Peng M; Wu N; Tang Y; Tian H; Zhou Y; Liao Q
Cancer Gene Ther; 2024 Jan; 31(1):9-17. PubMed ID: 38102462
[TBL] [Abstract] [Full Text] [Related]
5. Proteogenomic insights suggest druggable pathways in endometrial carcinoma.
Dou Y; Katsnelson L; Gritsenko MA; Hu Y; Reva B; Hong R; Wang YT; Kolodziejczak I; Lu RJ; Tsai CF; Bu W; Liu W; Guo X; An E; Arend RC; Bavarva J; Chen L; Chu RK; Czekański A; Davoli T; Demicco EG; DeLair D; Devereaux K; Dhanasekaran SM; Dottino P; Dover B; Fillmore TL; Foxall M; Hermann CE; Hiltke T; Hostetter G; Jędryka M; Jewell SD; Johnson I; Kahn AG; Ku AT; Kumar-Sinha C; Kurzawa P; Lazar AJ; Lazcano R; Lei JT; Li Y; Liao Y; Lih TM; Lin TT; Martignetti JA; Masand RP; Matkowski R; McKerrow W; Mesri M; Monroe ME; Moon J; Moore RJ; Nestor MD; Newton C; Omelchenko T; Omenn GS; Payne SH; Petyuk VA; Robles AI; Rodriguez H; Ruggles KV; Rykunov D; Savage SR; Schepmoes AA; Shi T; Shi Z; Tan J; Taylor M; Thiagarajan M; Wang JM; Weitz KK; Wen B; Williams CM; Wu Y; Wyczalkowski MA; Yi X; Zhang X; Zhao R; Mutch D; Chinnaiyan AM; Smith RD; Nesvizhskii AI; Wang P; Wiznerowicz M; Ding L; Mani DR; Zhang H; Anderson ML; Rodland KD; Zhang B; Liu T; Fenyö D;
Cancer Cell; 2023 Sep; 41(9):1586-1605.e15. PubMed ID: 37567170
[TBL] [Abstract] [Full Text] [Related]
6. [Epidemiological Panorama of Cervical Dysplasia in a First-Level Care Unit].
Seefoó-Jarquín P; Sosa-Jurado F; Maycotte-González P
Rev Med Inst Mex Seguro Soc; 2023 Mar; 61(2):155-162. PubMed ID: 37201194
[TBL] [Abstract] [Full Text] [Related]
7. Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.
Rosati A; Vargiu V; Certelli C; Arcieri M; Vizza E; Legge F; Cosentino F; Ferrandina G; Fanfani F; Scambia G; Corrado G
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6479-6488. PubMed ID: 36773091
[TBL] [Abstract] [Full Text] [Related]
8. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
9. Mechanistic analysis of endothelial lipase G promotion of the occurrence and development of cervical carcinoma by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase signalling pathway.
Huang J; Liu R; Zhang Y; Sheng X
J Obstet Gynaecol; 2023 Dec; 43(1):2151353. PubMed ID: 36606668
[TBL] [Abstract] [Full Text] [Related]
10. Ethnic disparity in cervical cancer stage at diagnosis: A retrospective study in an Israeli referral-center.
Levin G; Cohen L; Brandt B; Kogan L; Ben Simchon O; Perri T
Int J Gynaecol Obstet; 2023 Jun; 161(3):769-774. PubMed ID: 36565053
[TBL] [Abstract] [Full Text] [Related]
11. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/akt/mTOR signaling pathway.
Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
[TBL] [Abstract] [Full Text] [Related]
12. A progressive and refractory case of breast cancer with Cowden syndrome.
Sueta A; Takeno M; Goto-Yamaguchi L; Tomiguchi M; Inao T; Yamamoto-Ibusuki M; Yamamoto Y
World J Surg Oncol; 2022 Sep; 20(1):279. PubMed ID: 36057718
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of long-term sexual function of cervical cancer survivors after treatment: A cross-sectional study.
Wang HZ; He RJ; Zhuang XR; Xue YW; Lu Y
J Obstet Gynaecol Res; 2022 Nov; 48(11):2888-2895. PubMed ID: 36055894
[TBL] [Abstract] [Full Text] [Related]
14. Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer.
Lightfoot MDS; Felix AS; Calo CA; Hosmer-Quint JT; Taylor KL; Brown MB; Salani R; Copeland LJ; O'Malley DM; Bixel KL; Cohn DE; Fowler JM; Backes FJ; Cosgrove CM
Am J Obstet Gynecol; 2023 Jan; 228(1):59.e1-59.e13. PubMed ID: 35931127
[TBL] [Abstract] [Full Text] [Related]
15. Tissue-Based Proteomic Profiling in Patients with Hyperplasia and Endometrial cancer.
Akkour K; Alanazi IO; Alfadda AA; Alhalal H; Masood A; Musambil M; Rahman AMA; Alwehaibi MA; Arafah M; Bassi A; Benabdelkamel H
Cells; 2022 Jul; 11(13):. PubMed ID: 35805203
[TBL] [Abstract] [Full Text] [Related]
16. Nodal Assessment in Endometrial Atypical Hyperplasia.
Capozzi VA; Sozzi G; Butera D; Chiantera V; Ghi T; Berretta R
Gynecol Obstet Invest; 2022; 87(3-4):226-231. PubMed ID: 35793641
[TBL] [Abstract] [Full Text] [Related]
17. In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer.
Xiang N; Chen T; Zhao X; Zhao M
Tissue Cell; 2022 Aug; 77():101845. PubMed ID: 35679681
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial.
Chopra S; Goda JS; Mittal P; Mulani J; Pant S; Pai V; Kannan S; Deodhar K; Krishnamurthy MN; Menon S; Charnalia M; Shah S; Rangarajan V; Gota V; Naidu L; Sawant S; Thakkar P; Popat P; Ghosh J; Rath S; Gulia S; Engineer R; Mahantshetty U; Gupta S
BMJ Open; 2022 Apr; 12(4):e055765. PubMed ID: 35387819
[TBL] [Abstract] [Full Text] [Related]
19. G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo.
Zhu K; Deng C; Du P; Liu T; Piao J; Piao Y; Yang M; Chen L
Reprod Biol Endocrinol; 2022 Mar; 20(1):50. PubMed ID: 35277194
[TBL] [Abstract] [Full Text] [Related]
20. Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
DeBoer RJ; Umutoni V; Bazzett-Matabele L; Katznelson E; Nguyen C; Umwizerwa A; Bigirimana JB; Paciorek A; Nsabimana N; Ruhangaza D; Ntasumbumuyange D; Shulman LN; Triedman SA; Shyirambere C
Gynecol Oncol; 2022 Feb; 164(2):370-378. PubMed ID: 34916066
[TBL] [Abstract] [Full Text] [Related]
[Next]
